Gregory Adams, PhDChief Scientific Officer at Elucida Oncology
Agenda Sessions
Targeted C’Dot-drug Conjugates (CDCs), a Novel Nanoparticle-based Platform for the Treatment of Cancer
, 9:00amView Session